Cardiac Rehab Post-atrial Fib Ablation
Effect of Cardiac Rehabilitation Exercise on the Recurrence of Atrial Fibrillation in Post-ablation Patients: a Randomized Controlled Pilot Study
1 other identifier
interventional
40
1 country
1
Brief Summary
The aim of this study is to examine the effect of a 12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation (AF) in patients at six- and twelve-months post-ablation procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable atrial-fibrillation
Started May 2022
Shorter than P25 for not_applicable atrial-fibrillation
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 14, 2022
CompletedFirst Submitted
Initial submission to the registry
June 21, 2022
CompletedFirst Posted
Study publicly available on registry
July 11, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 14, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 13, 2024
CompletedFebruary 20, 2024
February 1, 2024
1.1 years
June 21, 2022
February 15, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
The aim of this study is to examine the effect of a 12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation (AF) in 40 patients at six- and twelve-months post-ablation procedure.
Examine the effect of a 12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation at 6- and 12-months post-ablation treatment.
12 months after the first intake appointment
Study Arms (2)
cardiac rehabilitation intervention group
EXPERIMENTALParticipants assigned to the intervention group will participate in pre-post assessments and a 12-week supervised exercise based cardiac rehabilitation program at a designated local Pulse Heart Institute Cardiac Rehabilitation program.
control group
NO INTERVENTIONParticipants assigned to the control group will participate in pre-post assessments and will maintain usual care and current activity levels.
Interventions
12-week exercise-based cardiac rehabilitation intervention on the recurrence of atrial fibrillation (AF) in patients at six- and twelve-months post-ablation procedure.
Eligibility Criteria
You may qualify if:
- ● Adult patients 18 years and older.
- Willing to participate in the study after randomization to either an intervention group (cardiac rehabilitation exercise) or a control group (usual care).
- Able to attend two pre and post study clinic visits at a local designated Pulse Heart Institute cardiac rehab program.
- If randomized to the cardiac rehab intervention group can attend exercise rehab visits for 3 x per week for 12 weeks (36 visits) at a designated Pulse cardiac rehab program.
- Has an active email address and phone number.
- Documented diagnosis of Paroxysmal and persistent Atrial Fibrillation.
- Undergone ablation treatment and is at a minimum of 2 weeks post ablation status.
- Compliant with medication therapy including medications for heart rate control and anticoagulant(s).
You may not qualify if:
- ● Does not speak English.
- Does not have clearance to participate in the study by their attending cardiologist.
- Documented cardiovascular disease or pulmonary/respiratory disease that would qualify the patient for Cardiac, Pulmonary or Vascular Rehabilitation at a Pulse Heart Institute rehabilitation program.
- Dementia or cognitive impairment.
- Unable to participate in rehabilitation exercise due to physical limitations.
- Greater than one prior ablation procedure
- Long standing, chronic Atrial Fibrillation
- Patients who have undergone posterior wall isolation ablation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tacoma General Hospital
Tacoma, Washington, 98415, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 21, 2022
First Posted
July 11, 2022
Study Start
May 14, 2022
Primary Completion
June 14, 2023
Study Completion
January 13, 2024
Last Updated
February 20, 2024
Record last verified: 2024-02